Which laboratory studies are recommended for the evaluation of anemia?

Laboratory Evaluation of Anemia

The essential laboratory studies for evaluating anemia include a complete blood count (CBC) with hemoglobin, reticulocyte count, and iron studies (serum ferritin and transferrin saturation), with additional testing guided by the CBC findings and clinical context. 1

Initial Core Laboratory Tests

Complete Blood Count (CBC)

• Hemoglobin is the preferred measure over hematocrit because it has superior reproducibility across laboratories, lower coefficients of variation, and is not affected by sample storage time or patient variables like serum glucose 1
• The CBC must include white blood cells, hemoglobin, and platelets to assess overall bone marrow function 1
• Mean corpuscular volume (MCV) provides critical classification information: low MCV suggests iron, folate, or B12 deficiency or inherited hemoglobin synthesis disorders 1
• Abnormalities in two or more cell lines warrant hematology consultation 1

Reticulocyte Count

• Use either absolute count or reticulocyte index (adjusted for degree of anemia) to evaluate bone marrow response appropriateness 1
• Low reticulocyte count indicates inadequate bone marrow response from absent/unavailable iron, red cell production defects, insufficient erythropoietin, or inflammation 1
• Elevated reticulocyte count suggests hemolysis or blood loss and directs further workup accordingly 2, 3, 4

Iron Studies (Essential for All Anemia Evaluations)

• Serum ferritin serves as the surrogate marker for tissue iron stores 1
  • In non-dialysis CKD patients: ferritin <25 ng/mL (males) or <11 ng/mL (females) predicts insufficient iron stores 1
  • Caveat: Ferritin is an acute-phase reactant and may be falsely elevated with inflammation, chronic kidney disease, or other inflammatory states 1
• Transferrin saturation (TSAT) represents iron available to bone marrow for erythropoiesis 1
  • More reliable than ferritin in CKD patients because it is less affected by inflammation 1
• For iron deficiency anemia diagnosis: ferritin <45 ng/mL in the appropriate clinical context 1

Additional Testing Based on MCV Classification

Microcytic Anemia (Low MCV)

• Complete iron panel if not already done 5, 2, 6, 4
• Lead levels in appropriate clinical contexts 4
• Hemoglobin electrophoresis to evaluate for thalassemia or hemoglobinopathies 2, 4

Macrocytic Anemia (High MCV)

• Vitamin B12 level 5, 2, 6, 4
• Folate level 5, 2, 6, 4
• Thyroid function testing 4

Normocytic Anemia (Normal MCV)

• Workup is guided by reticulocyte count 3, 4
• If elevated reticulocyte count: evaluate for blood loss or hemolysis with lactate dehydrogenase, haptoglobin, and bilirubin levels 5, 3
• If low reticulocyte count: consider bone marrow disorders or aplasia 3, 4

Supplemental Studies When Indicated

Peripheral Blood Smear

• Provides morphologic information that can guide diagnosis across all anemia types 5, 2, 3, 4
• Particularly useful when CBC findings are unclear or suggest specific diagnoses 3

Hemolysis Evaluation (When Reticulocyte Count Elevated)

• Lactate dehydrogenase (LDH) 5
• Haptoglobin 5
• Bilirubin (indirect) 5

Gastrointestinal Evaluation for Iron Deficiency

• Non-invasive testing for H. pylori and celiac disease should be performed before endoscopy in asymptomatic patients with iron deficiency anemia 1
• Bidirectional endoscopy is strongly recommended for men and post-menopausal women with iron deficiency anemia after negative non-invasive testing 1

Important Clinical Pitfalls

• Do not rely on ferritin alone in patients with inflammation, CKD, or chronic disease as it may be falsely elevated; use transferrin saturation as a more reliable marker in these contexts 1
• Finding iron deficiency in non-dialysis CKD patients without menstrual losses or known iron loss should prompt evaluation for gastrointestinal bleeding 1
• Interpret ferritin thresholds in context: the cutoff of <45 ng/mL for iron deficiency anemia applies to general populations, but different thresholds apply in CKD populations 1